Thursday, February 28, 2019 11:53:36 AM
I was also thrown by one statement of a doctor in Australia whom was commenting on the usage of Pantheris from the below article:
https://finance.yahoo.com/news/avinger-announces-commercial-launch-australia-130000421.html
The bolded comment from the doctor's excerpt in the article told me that this product is just "another option" and not the sole option, or market leader it is hoping to be.
All IMO.
Recent AVGR News
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 03/08/2024 09:31:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:13 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:41:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 10:21:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2024 09:17:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 09:11:36 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/10/2024 10:11:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:05:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 10:02:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:30:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/01/2023 09:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 01:30:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 09:32:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/22/2023 09:32:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 09:05:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 08:35:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 08:31:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 08:09:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/22/2023 10:06:54 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/22/2023 10:03:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/21/2023 10:05:05 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/21/2023 10:02:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 10:05:22 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/20/2023 10:02:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 08:56:15 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM